Clinical trial Recruiting at 1 site Interventional Ages 21 to 45 Women only

Monitoring glucose levels in pregnant women to improve gestational diabetes diagnosis

Official title: Integrated Continuous Glucose Monitoring Glycemic cHAracterization During Pregnancy in Comparison With OGTT (I-CHAP)

Run by KK Women's and Children's Hospital · NCT06357728 · Data updated 2026-11-12

This study is testing if using a continuous glucose monitor can help better diagnose gestational diabetes in pregnant women of Chinese and Indian descent.

More Metabolic Disease trials

Quick facts

Study typeInterventional
Ages21 Years to 45 Years
SexWomen only
Enrollment60 (estimated)
SponsorKK Women's and Children's Hospital
Government
Locations1 site (Singapore, Singapore)
StatusRecruiting
StartedJuly 1, 2024
Main results expectedDecember 1, 2026
Study endsDecember 1, 2026
Registry record updatedAugust 10, 2026
Trial IDNCT06357728 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are pregnant women of Chinese or Indian ethnicity, aged 21-45 years, who are scheduled for an OGTT between 20-35 weeks of gestation.

Probably not a fit

Patients with pre-existing Type 1 or Type 2 diabetes, serious skin conditions, or mental illnesses that prevent informed consent may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the use of continuous glucose monitoring (CGM) to better diagnose gestational diabetes mellitus (GDM) in pregnant women of Chinese and Indian ethnicity. It aims to correlate CGM glucose values with traditional oral glucose tolerance test (OGTT) results and assess the impact of glucose variability on maternal and fetal outcomes. By focusing on a specific population in Singapore, the study seeks to provide valuable insights into the effectiveness of CGM in managing GDM and improving pregnancy outcomes. The research will involve a single-arm intervention where participants will wear a CGM device during their pregnancy.

Why it matters

Potential benefit: If successful, this study could lead to improved diagnosis and management of gestational diabetes, ultimately enhancing maternal and fetal health outcomes.

How similar studies have gone: While the use of CGM in pregnancy is gaining attention, this specific approach focusing on GDM diagnosis in an Asian population is relatively novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Pregnant women of only Chinese or Indian ethnicity
2. Pregnant women between age 21--45 years old
3. Oral glucose tolerance test (OGTT) to be scheduled between 20-35 weeks gestational age
4. OGTT to be done at KK Women's and Children's Hospital

Exclusion Criteria:

1. Women with serious skin conditions (e.g. eczema) that precludes wearing the sensor for 10 days
2. Exclusion criteria were pre-existing Type 1 or Type 2 diabetes, mental illness precluding informed consent and women who were diagnosed early (1st or early 2nd trimester for GDM).

Where it's running

  • KK Women's and Children's Hospital
    Singapore, Singapore, Singapore
    Recruiting

Study contacts

  • Principal investigator: Phaik Ling, Elaine Quah, PhD — KK Women's and Children's Hospital
  • Study coordinator: Phaik Ling, Elaine Quah, PhD
  • Email: quah.phaik.ling@kkh.com.sg
  • Phone: 65 97732543

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Network for studying rare and atypical diabetes

    This study is trying to find and understand rare types of diabetes by testing people and families who haven't been diagnosed yet, using blood tests and genetic screening to learn more about these conditions.

    Recruiting at 13 sites University of South Florida · Aurora, Colorado and 12 other locations · NCT05544266

  • Cognitive-behavioral therapy and exercise training for teenage girls at risk for type 2 diabetes

    This study is testing if cognitive-behavioral therapy, exercise training, or both can help teenage girls at risk for type 2 diabetes improve their health and reduce stress and depression.

    Recruiting at 2 sites Colorado State University · Aurora, Colorado and 1 other locations · NCT05543083

  • Real-time continuous glucose monitoring for young adults at risk of DKA

    This project will try a Dexcom G6 real-time continuous glucose monitor to see if it helps 18-25-year-olds with insulin-treated diabetes who have poor blood sugar control or recent hospital admissions for high blood sugar.

    Recruiting Imperial College London · London · NCT04039763

  • Early Glucose Patterns in Pregnant Women at Risk for GDM

    This study tests whether continuous glucose monitoring in early pregnancy can detect dysglycemia before GDM is diagnosed, in women with and without known risk factors.

    Recruiting DCB Research AG · Bern, Canton of Bern · NCT07783178

  • AMX0035 in adults with Type 1 Diabetes

    This study tests whether 24 weeks of the oral medication AMX0035 help improves metabolic health in adults with Type 1 Diabetes compared with a placebo.

    Recruiting Phase 2 University of Washington · Seattle, Washington and 1 other locations · NCT07699380

  • Probiotic-augmented therapy for gestational diabetes

    This trial tests whether adding multistrain probiotics to metformin, insulin, or their combination can improve blood sugar control and inflammation in pregnant women with gestational diabetes.

    Recruiting Riphah International University · Rawalpindi, Punjab Province · NCT07645001

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.